Interventional device developer Boston Scientific of Natick, MA, has made an equity investment in REVA Medical, a privately held interventional device company located in San Diego. The investment also gives Boston Scientific an exclusive option to purchase REVA.
REVA is developing a balloon-expandable, bioresorbable drug-eluting stent that combines distinctive geometry and resorbable polymer properties. The REVA stent is designed to perform comparably to metallic drug-eluting stents, and then be resorbed by the body once the artery has healed, Boston Scientific said.
Terms of the agreement were not disclosed.
By AuntMinnie.com staff writers
November 16, 2004
Related Reading
Boston Scientific posts strong Q3, October 19, 2004
SonoSite, Boston Scientific team up, August 11, 2004
Boston Scientific recalls more stents, shares drop, August 6, 2004
Boston Scientific's Taxus stent back at Brigham, August 2, 2004
Boston Scientific gets FDA nod for Liberte clinical trial, July 22, 2004
Copyright © 2004 AuntMinnie.com
